Dr Maluquer de Motes added: "Mpox control has to climb up the global health agenda. We have limited diagnostic tools and even fewer antiviral treatments. We urgently need better surveillance and ...
News-Medical.Net on MSN4d
Research highlights rising risk of human-to-human mpox transmissionMpox has the potential to become a significant global health threat if taken too lightly, according to scientists at the University of Surrey.
New Vision on MSN11d
Risky sexual behaviour fueling Mpox — ExpertsI battled a high fever for six days, and just as it started to improve, I noticed a large, painful abscess in my private parts,” recalls Emily Nayebale, 27. ;A single mother of one, Nayebale first ...
The only antiviral recognised as an mpox treatment was unable to shorten the time to resolution of lesions in a trial in the Democratic Republic of the Congo (DRC), the epicentre of an outbreak ...
The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox lesions or improve pain control among adults in an international ...
Dr Maluquer de Motes added: “Mpox control has to climb up the global health agenda. We have limited diagnostic tools and even fewer antiviral treatments. "We urgently need better surveillance ...
Denmark's Bavarian Nordic said on Monday the U.S. Food and Drug Administration has approved a freeze-dried formulation of its ...
The Miti Murhesa treatment center is fast running out of supplies. Mubake Buroko Patrick, an mpox patient at the facility, said it was difficult to get drugs in the weeks following the fighting.
A new mutated variant of Mpox has been identified in Democratic Republic of Congo, with health authorities concerned over increased transmissibility. The new variant comes from the clade 1a strain ...
“This study brought us a step forward in better understanding mpox disease and potential treatment strategies,” said Jeanne Marrazzo, M.D., M.P.H., director of NIH’s National Institute of ...
“This study brought us a step forward in better understanding mpox disease and potential treatment strategies,” said Jeanne Marrazzo, M.D., M.P.H., director of NIH’s National Institute of Allergy and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback